DE60034888D1 - N-substituierte l-aminosäuren enthaltende peptide, zur prävention der beta-strang assoziation - Google Patents

N-substituierte l-aminosäuren enthaltende peptide, zur prävention der beta-strang assoziation

Info

Publication number
DE60034888D1
DE60034888D1 DE60034888T DE60034888T DE60034888D1 DE 60034888 D1 DE60034888 D1 DE 60034888D1 DE 60034888 T DE60034888 T DE 60034888T DE 60034888 T DE60034888 T DE 60034888T DE 60034888 D1 DE60034888 D1 DE 60034888D1
Authority
DE
Germany
Prior art keywords
peptide
beta
strand
substituted
nalpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60034888T
Other languages
English (en)
Inventor
Kelvin Stott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senexis Ltd
Original Assignee
Senexis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senexis Ltd filed Critical Senexis Ltd
Application granted granted Critical
Publication of DE60034888D1 publication Critical patent/DE60034888D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60034888T 1999-07-28 2000-07-28 N-substituierte l-aminosäuren enthaltende peptide, zur prävention der beta-strang assoziation Expired - Lifetime DE60034888D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9917724.8A GB9917724D0 (en) 1999-07-28 1999-07-28 Peptides
PCT/GB2000/002901 WO2001007473A1 (en) 1999-07-28 2000-07-28 Peptides containing n-substituted l-amino acids for preventing beta-strand association

Publications (1)

Publication Number Publication Date
DE60034888D1 true DE60034888D1 (de) 2007-06-28

Family

ID=10858096

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60034888T Expired - Lifetime DE60034888D1 (de) 1999-07-28 2000-07-28 N-substituierte l-aminosäuren enthaltende peptide, zur prävention der beta-strang assoziation

Country Status (10)

Country Link
US (1) US7125838B1 (de)
EP (1) EP1203019B1 (de)
JP (1) JP2003505469A (de)
AT (1) ATE362487T1 (de)
AU (1) AU766992B2 (de)
CA (1) CA2378779A1 (de)
DE (1) DE60034888D1 (de)
GB (1) GB9917724D0 (de)
NZ (1) NZ516441A (de)
WO (1) WO2001007473A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050026165A1 (en) 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
WO2002097444A2 (en) * 2001-05-31 2002-12-05 Arete Associates Misfolded protein sensor method
DE10230141B4 (de) * 2002-07-04 2004-07-15 Priontype Gmbh Verfahren und Kit zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc)
EP1532170A2 (de) * 2002-07-08 2005-05-25 Applied Research Systems ARS Holding N.V. Beta-faltblatt brechende peptide
EP1618129A2 (de) * 2003-04-30 2006-01-25 Applied Research Systems ARS Holding N.V. Inhibitoren von beta-amyloid und deren verwendung
WO2006088823A2 (en) * 2005-02-15 2006-08-24 Adlyfe, Inc. Method for detecting misfolded proteins and prions
EP2913056A1 (de) 2006-01-05 2015-09-02 The University of Utah Research Foundation Verfahren und Zusammensetzungen in Zusammenhang mit der Verbesserung von Eigenschaften pharmakologischer Wirkstoffe für das Nervensystem
JP5097206B2 (ja) * 2006-07-28 2012-12-12 エイディーライフ インコーポレイティッド 診断および治療のためのペプチドプローブ
US9364449B2 (en) 2010-06-09 2016-06-14 New York University Peptoid and synthetic oligomers, pharmaceutical compositions and methods of using same
WO2012082942A2 (en) 2010-12-15 2012-06-21 Neuroadjuvants, Inc. Neuropeptide analogs, compositions, and methods for treating pain
US9579358B2 (en) 2011-10-10 2017-02-28 Lancaster University Business Enterprises Limited Compositions for binding to amyloid proteins
BR112022006537A2 (pt) * 2019-11-07 2022-07-05 Nutricia Nv Processo para preparar um hidrolisado de proteína de soro do leite ultrafiltrado, hidrolisados de proteína de soro do leite ultrafiltrado, composição de hidrolisado de proteína de soro do leite, composições nutricionais, uso da composição nutricional e uso do hidrolisado de proteína de soro do leite ultrafiltrado

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996028471A1 (en) * 1995-03-14 1996-09-19 Praecis Pharmaceuticals Incorporated Modulators of amyloid aggregation
EP0866805A1 (de) 1995-12-12 1998-09-30 Karolinska Innovations AB Peptide, das die KLVFF Sequenz von beta-Amyloid bindet
US6034211A (en) * 1996-06-03 2000-03-07 Kelly; Jeffery W. β-sheet nucleating peptidomimetics
DE19725619A1 (de) 1997-06-17 1998-12-24 Fraunhofer Ges Forschung Peptide als Agonisten und/oder Inhibitoren der Amyloidbildung und Zytotoxizität sowie der Verwendung bei Alzheimer'schen Krankheit, beim Typ II Diabetes mellitus und bei spongiformen Encephalopathien

Also Published As

Publication number Publication date
AU6173700A (en) 2001-02-13
WO2001007473A1 (en) 2001-02-01
EP1203019B1 (de) 2007-05-16
AU766992B2 (en) 2003-10-30
EP1203019A1 (de) 2002-05-08
JP2003505469A (ja) 2003-02-12
NZ516441A (en) 2003-11-28
US7125838B1 (en) 2006-10-24
ATE362487T1 (de) 2007-06-15
GB9917724D0 (en) 1999-09-29
CA2378779A1 (en) 2001-02-01

Similar Documents

Publication Publication Date Title
DE60034888D1 (de) N-substituierte l-aminosäuren enthaltende peptide, zur prävention der beta-strang assoziation
SI1549333T1 (sl) Analogi kompstatina z izboljĺ ano aktivnostjo
AR051512A1 (es) Proteina de fusion que comprende un dominio bh3 de una proteina "solo bh3"
UA103154C2 (uk) Hla-a*1101-обмежений пептид wt1 і фармацевтична композиція, яка містить його
SE0002202D0 (sv) New peptides
HK1093308A1 (en) Use of peptides derived from the b beta chain of human fibrinogen for the treatment of shock
DE60033668D1 (de) N-substituierte d-aminosäuren enthaltende peptide, zur prävention der beta-strang assoziation
ATE279432T1 (de) Kininogen-inhibitoren
DE60233558D1 (de) Aminosäurezusammensetzungen zur linderung einer fehlfunktion der leber
EA200800205A1 (ru) Кальций-пептидный компонент
DE602004028266D1 (de) Angiogene peptide und ihre verwendungen
ATE432984T1 (de) Von mage-10 oder mage-8 abgeleitete hla-a2.1- bindende oligopeptide
DE69812597D1 (de) Peptide zur Inhibition von HPV E7 Proteinen
ATE46173T1 (de) Pharmakologisch aktive peptide.
Nakagomi et al. Isolation of novel peptides, cabin-1,-2,-3, and-4, that inhibit cathepsin B from a thermolysin digest of human plasma
HK1083850A1 (en) Peptides binding the phosphatase 2a protein and polynucleotides encoding same
EP1724346A3 (de) An die Lck-SH3 und Hck-SH3 Domäne bindende Peptide
SE9804137D0 (sv) New peptides
BRPI0216042B8 (pt) polipeptídeo capaz de se ligar a ang-2, vetor de expressão, célula hospedeira, composição farmacêutica, e, uso dos referidos polipeptídeos.

Legal Events

Date Code Title Description
8332 No legal effect for de